Stockscreener 앱 받기
0.4552
6.76%
-0.033
전일 마감가:
$0.4882
열려 있는:
$0.455
하루 거래량:
168.68K
Relative Volume:
0.40
시가총액:
$1.70M
수익:
$792.00K
순이익/손실:
$-12.69M
주가수익비율:
-0.0207
EPS:
-22
순현금흐름:
$-10.55M
1주 성능:
+0.66%
1개월 성능:
-7.57%
6개월 성능:
-63.29%
1년 성능:
-92.84%
1일 변동 폭
$0.4532
$0.5008
1주일 범위
$0.4151
$0.52
52주 변동 폭
$0.373
$9.50
Helius Medical Technologies Inc Stock (HSDT) Company Profile
명칭
Helius Medical Technologies Inc
전화
215-944-6100
주소
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
HSDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.4552 | 1.70M | 792.00K | -12.69M | -10.55M | -22.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-24 | 개시 | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc 주식(HSDT)의 최신 뉴스
Newtown-based Helius Medical Technologies Explores ‘Strategic Alternatives’ to Boost Stockholder Value - BUCKSCO.Today
Helius Medical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Helius Medical Technologies Reports Q3 2024 Earnings - TipRanks
Helius Medical Technologies Considers Strategic Alternatives Amid Financial Challenges - MSN
Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Modular Medical announces proposed public offering - MSN
Helius to explore 'strategic alternatives' with revenue from flagship product stunted by pricing issues - The Business Journals
Helius Medical Explores Strategic Alternatives - Marketscreener.com
Regenxbio down 13% ahead of data readout for muscular dystrophy asset - MSN
Grandshores Technology Expects Increased Loss Amid Forex Challenges - MSN
Helius Medical Technologies Initiates Strategic Alternatives to Maximize Stockholder ValueNEWTOWN, Pa., Nov. 18, 2024 / Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced on November 18, 2024, the initiation of a process to explore strategic - Defense World
Helius seeks fair market access for MS treatment device By Investing.com - Investing.com Australia
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives - GlobeNewswire
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for Its Portable Neuromodulation Stimulator Device - Marketscreener.com
Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance - TipRanks
Helix Biopharma announces CFO resignation - MSN
Helius Medical Technologies Challenges CMS Over PoNS Payment Rates - MSN
Helius Medical Technologies to Shine at ThinkEquity Conference in NYC! - MSN
Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 2024 - The Manila Times
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference - GlobeNewswire Inc.
Adversity is less terrifying than hope: Helius Medical Technologies Inc (HSDT) - SETE News
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes - Investing.com India
HSDT’s Market Whiplash: -95.35% YTD Decline, -53.82% Plunge in 30 Days - The InvestChronicle
Maxim cuts Helius Medical shares to hold on CMS reimbursement woes By Investing.com - Investing.com South Africa
Financial Health Check: Examining Helius Medical Technologies Inc (HSDT)’s Key Ratios - The Dwinnex
Helius to challenge CMS’ reimbursement determination for PoNS - Medical Buyer
Helius challenges CMS over PoNS device reimbursement rate - Investing.com India
Helius challenges CMS over PoNS device reimbursement rate By Investing.com - Investing.com South Africa
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece - The Manila Times
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from - The Bakersfield Californian
Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire
Helius Medical stock hits 52-week low at $0.5 amid sharp decline By Investing.com - Investing.com South Africa
Helius Medical stock hits 52-week low at $0.5 amid sharp decline - Investing.com
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN
Financial Health Report: Helius Medical Technologies Inc (HSDT)’s Ratios Tell a Tale - The Dwinnex
HSDT stock touches 52-week low at $0.55 amid sharp annual decline By Investing.com - Investing.com South Africa
HSDT stock touches 52-week low at $0.55 amid sharp annual decline - Investing.com India
HSDT’s price-to-sales ratio: A comparative analysis with its peers - US Post News
Helius reports positive preliminary PoNS study results for MS - Investing.com
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study - GlobeNewswire
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Large Growth in Short Interest - Defense World
Is The Market Rewarding Helios Technologies, Inc. (NYSE:HLIO) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Yahoo Finance
Taking a Closer Look At Harmonic, Inc. (HLIT) Following Its Recent Trade - Knox Daily
Helios Technologies Extends History of Quarterly Dividends With 111th Consecutive Cash Dividend - Business Wire
Halfords Group (OTCMKTS:HLFDY) Stock Price Down 3.1% - Defense World
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’ - Stockhead
Helius Medical Technologies Inc (HSDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):